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Abstract
Probabilistic association discovery aims at identifying the association between random vec-
tors, regardless of number of variables involved or linear/nonlinear functional forms. Re-
cently, applications in high-dimensional data have generated rising interest in probabilistic
association discovery. We developed a framework based on functions on the observation
graph, named MeDiA (Mean Distance Association). We generalize its property to a group of
functions on the observation graph. The group of functions encapsulates major existing
methods in association discovery, e.g. mutual information and Brownian Covariance, and
can be expanded to more complicated forms. We conducted numerical comparison of the
statistical power of related methods under multiple scenarios. We further demonstrated the
application of MeDiA as a method of gene set analysis that captures a broader range of re-
sponses than traditional gene set analysis methods.
Introduction
In the analysis of high-throughput biological data, such as gene expression data, proteomics
data, and metabolomics data, it is often of interest to examine the behavior of groups of vari-
ables (genes, proteins or metabolites). The grouping of the variables are commonly pre-deter-
mined by functional annotations of the biological units using databases, e.g. Gene Ontology [1]
or KEGG pathways [2]. A number of methods were developed in the area of gene set analysis
to test for shifts of overall expression levels of genes involved in a gene set under different treat-
ment conditions [3–5]. This approach is commonly referred to as gene set analysis. Besides an-
alyzing the behavior of each gene set in response to certain biological conditions, another class
of methods examine the relations between gene sets, both under a single treatment condition
[6] and between different treatment conditions [7–9].
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So far most of the methods developed for the analysis of gene sets are based on linear rela-
tions between random variables. However complex and nonlinear relations between genes and
between a gene and treatment condition has been documented [10–12]. Utilizing general prob-
abilistic associations beyond linear association could produce more insights into the data.
If we consider each gene set as a random vector consisting of multiple random variables
(genes), seeking association between gene sets boils down to finding probabilistic associations
between two random vectors. In this manuscript we first propose and generalize new methods
to discover probabilistic association between random vectors. Then we demonstrate the utility
of such measures in finding the general dependency between gene sets and multi-dimensional
clinical outcomes.
Consider two random vectors X and Y and n pairs of independent and identically distribut-
ed (i.i.d.) random samples fxi; yigni¼1. We would like to draw inference for the existence of
probabilistic association between X and Y based on the n pairs of samples. The discussion in
this paper will focus on the probabilistic association between continuous random variables de-
fined in the Euclidean space.
Classical association statistics like Pearson’s correlation coefficient assume functional forms
(for example, piecewise linear, monotonicity) between X and Y, which are judged as correlated
if Corr(X,Y)6¼0. Probabilistic association statistic, as the name suggests, perceives associations
from the level of probabilistic dependence. That is, X and Y are judged as independent if and
only if their joint probability density function can be factored, F(X,Y) = FX(X)FY(Y), where F()
is the probability density function for the random vector under consideration. Probabilistic as-
sociation encapsulates a larger group of associations than traditional correlation coefficient.
For example, probabilistic association would consider nonlinear interactions involving
multiple variables.
There are multiple methods on probabilistic association discovery linked to functions on
the observation distance graph. The distance graph consists of nodes representing each obser-
vation (xi, yi) in the p+q dimensional Euclidean space. Here p and q are the dimensions of X
and Y, respectively. Edges of the observation graph would connect two nodes (observations) if
specific criteria are satisfied. For example, mutual information and its derivatives have been the
most popular probabilistic association statistic to date [11,13]. To estimate mutual information,
the joint entropy can be approximated using log-transformed K-nearest neighbour distance av-
eraged for each observation [14–16].
Recent breakthrough on distance covariate sheds light on universal association discovery
with simplicity and theoretical flexibility [17,18]. Brownian distance covariate was defined as
V2N ¼ 1n2
Pn
k;l¼1D
X
klD
Y
kl, where D
X
kl and D
Y
kl are linear functions of pairwise distances between sam-
ple elements calculated with X and Y dimensions, respectively [17]. Given fixed marginal dis-
tribution for X and Y, large Brownian distance covariate suggests the existence of probabilistic
association.
In this manuscript, we first describe a general framework for nonlinear association based on
the observation graph. It can incorporate different distance metrics and weighting schemes.
We then discuss two specific forms of associations including their properties, and illustrate
their performance in simulations. Next we show such metrics can be successfully used in non-
linear gene set analysis, which can incorporate multivariate outcome variables, nonlinear asso-
ciations, and within-gene set heterogeneity.
Mean Distance Association and Nonlinear Gene Set Analysis
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Methods
The general form of association based on observation graph
We propose the general form of association as
M ¼Pnk¼1Pl 6¼kDðX;YÞkl wkl; k ¼ 1; . . . ; n; l ¼ 1; . . . n ð1Þ
where n is the total number of data points, DðX;YÞkl is the distance between data points calculated
using both X and Y dimensions, and wkl is the weight depending on the specific considerations
of the data. This can be seen as a general framework when we consider different distance met-
rics and weighting schemes can be used. We describe two specific types of association scores in
the following sections.
Mean Distance Association (MeDiA) score
We let wkl ¼ 12
n
2
 !1
, then the score is the mean distance between all pairs of points in the
joint space of (X,Y). We are interested in testing the existence of Probabilistic association between
two random vectors (X,Y), given n pairs of observations. Consider another pair of random vec-
tors (~X, ~Y), where ~X follows independent and identical distribution (i.i.d.) as X and ~Y follows i.i.
d. distribution as Y. The only difference is that ~X and ~Y are mutually independent. As mentioned
above, we would like to compare the sample observation distance from (X,Y) against that from
(~X, ~Y). Intuitively, when X and Y are probabilistically associated, the point cloud occupies a
smaller space, hence the mean distance tends to be smaller than that from (~X, ~Y).
Theorem 1. Denote the distance between two independent random samples from (X, Y) as
dXY, and the distance between two independent random samples from (~X, ~Y) as d~X ~Y . Then we
have
EðdXYÞ  Eðd~X ~YÞ
Proofs of the theoretical results in this section are presented in S1 File. Theorem 1 confirms
our intuition: when two random vectors are probabilistically associated, their observations
tend to be closer compared with their independent counterparts. Denote distances between
two random observations as dij, where i and j are the indices among the n observations. We
have the following property:
Corollary 1. For a given observation i, define its mean peer distance as Eq 2. Also define
the mean observation distance for n observations as Eq 3:
di ¼
1
n 1
X
i6¼j
dij; 8i ð2Þ
M ¼ 1
n
P
i
di ð3Þ
Under the null hypothesis that random vectors X and Y are independent, the mean observa-
tion distance follows asymptotic normal distribution as n!1.
Corollary 1 is easily proved using the Central Limit Theorem. Based on Corollary 1, we can
approximate the null distribution of mean distance using normal distribution, which alleviate
the computational burden of the permutation test when n is reasonably large.
Mean Distance Association and Nonlinear Gene Set Analysis
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Mean Distance Association using Nearest Neighbor (MeDiANN)
We let wkl = 1/n when the involved elements are nearest neighbors, and wkl = 0 otherwise. The
association score becomes:
~di ¼ minðdi1; . . . ; dinÞ
M ¼ 1
n
X
i
~di
ð4Þ
MeDiANN also enjoys asymptotic normality following Bickel and Breiman [19]. That is, re-
gardless of the joint distribution of (X, Y) or the norm used to define the distance, the MeD-
iANN scoreM follows
1ffiffiffi
n
p ðM  EðMÞÞ ! Nð0; s2Þ as n!1
where E(M) is the expectation of the MeDiANN scoreM, and σ is the asymptotic standard de-
viation. This property leads to the proposal of Gaussian plug-in permutation test in the next
section, and reduces the computational burden of simulating the score distribution under the
null hypothesis of independence between X and Y.
Using Gaussian plug-in permutation test for inference
Following theoretical results from the sub-sections above, we propose a permutation test of
probabilistic association using MeDiA or MeDiANN. Given n pairs of observations fxi; yigni¼1,
the null distribution of the test statistic is generated with the following procedure:
1. Permute relative indices of samples fxi; yigni¼1, i.e. generate random pairing between the x’s
and y’s, and calculate MeDiA or MeDiANN score after permutation.
2. Repeat the above step K times and record all the scores, denoted as fM^ kgk¼1;...;K: Calculate
mean and and standard deviation of fM^ kgk¼1;...;K , denoted as ðm^; s^Þ.
3. Approximate the null distribution using normal distribution with mean and standard devia-
tion equaling to ðm^; s^Þ.
4. Compare the scoreM from the actual data with the approximated null distribution, and
generate one-sided p-value of the test, p ¼ F Mm^s^
 
.
Results
A simple example
We show a simple example in Fig 1. Both plots show 300 samples from two bivariate random
vectors. Observations on the left panel were sampled from independent bivariate normal distri-
butions. Observations on the right panel were sampled from a mixture bivariate normal distri-
bution. Half of the samples were from a bivariate normal distribution with variance-covariance
matrix of
1 0:8
0:8 1
 !
, and the other half of the samples were from a bivariate normal distri-
bution with variance-covariance matrix of
1 0:8
0:8 1
 !
.
Both distributions in Fig 1A and 1B have standard normal marginal distribution and zero
correlation coefficient. However, the two samples differ on a group of metrics defined on the
Mean Distance Association and Nonlinear Gene Set Analysis
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observation distances. Table 1 shows the mean distance, mean nearest neighbor distance, and
mean log-nearest neighbor distance are all smaller for the dependent case (Fig 1B) compared
with independent case (Fig 1A).
Numerical Comparison
For a more systematic assessment of the performance of the proposed method, we conducted a
simulation study to examine the size and statistical power of the tests, together with two com-
monly used non-linear association statistics—the mutual information (MI) and the Brownian
covariance (dCov).
The power of the above methods are compared using simulation under scenarios below:
• Linear association: X and Y are both p-dimensional random vectors. (X,Y) follow multivari-
ate normal distribution with zero mean, unit variance and covariance of ρ between all pairs
of random variables.
• Variance association: X follows p-dimensional normal distribution with zero mean, unit
variance, and zero covariance. Y is a p-dimensional random vector. yi,j is sampled from N(0, |
xi,j|), i = 1,. . .,p, j = 1,. . .,n.
• Sine curve association: X is sampled from p-dimensional normal distribution with zero
mean, unit variance, and zero covariance. Then xi is linearly scaled to between 0 and 2π.
yi;j ¼ sinðxi;j þ xiÞ þ i;j, i = 1,. . .,p, j = 1,. . .,n, xi  Unifð0;2pÞ; i;j  Nð0; s2Þ: Square
function association X follows p-dimensional normal distribution with zero mean, unit vari-
ance, and zero covariance. yi;j ¼ x2i;j þ i;j, i = 1,. . .,p, j = 1,. . .,n, i;j  Nð0; s2Þ:
For each of the above scenarios, we generated n pairs of random samples. We tested the ex-
istence of association using MeDiA, MeDiANN, MI and dCov. We used p = 3 for all cases. The
sample size n ranged from 25 to 500. For the linear association case, we used ρ = 0.5, which is a
Fig 1. Random samples generated from independent bivariate normal distribution (left), andmixture
bivariate normal distribution with ±0.8 covariates (right). The dashed lines connects two observations if
they are nearest neighbors.
doi:10.1371/journal.pone.0124620.g001
Table 1. Comparison between the independent bivariate normal distribution andmixture normal dis-
tribution in Fig 1.
Metric Left (Independent) Right (Mixed Normal)
mean distance (MeDiA) 1.81 1.70
mean nearest neighbor distance (MeDiANN) 0.14 0.12
mean log(nearest neighbor distance) -2.24 -2.43
doi:10.1371/journal.pone.0124620.t001
Mean Distance Association and Nonlinear Gene Set Analysis
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relatively weak pairwise correlation level in real data. For the sine curve and square function as-
sociations, a noise term was involved. We used a noise level such that the signal variance is half
that of the noise, which is a relatively high noise level in real data. For each scenario/method/
sample size tuple, we repeated the simulation 400 times. The p-value for each simulation was
recorded. And finally the power for each method under each scenario and sample size combi-
nation is calculated as the percentage of tests with p-values smaller than 0.05.
Power comparison shows differentiated method performance in different scenarios. MeD-
iANN is defined as average nearest neighbor observation graph edge length. The version of MI
used here is estimated as average log-transformed nearest neighbor edge length. They share
similar power possibly due to the similar forms of estimation. Nonetheless, there are cases
where one is better than the other.
In the linear association scenario, dCov and MeDiA performed almost identically. Both are
better than the other two methods (Fig 2, lower-left panel). There is a tight connection between
Pearson correlation and Brownian Covariate under multivariate normal distributions [17]. At
the same time, the data points generated from the joint density function tend to be closer to the
diagonal compared to the independent case, causing the average pairwise distance to be
smaller, which allows sufficient power for MeDiA. The average distance to the nearest neighbor
is reduced not as much as the average pairwise distance. Thus the MiDiANN and MI showed
lower power than dCov and MeDiA when the sample size is not large.
In the square function association case, MeDiA outperformed the other three methods (Fig
2, upper-left panel). To understand the result, we consider a simple case where both X and Y
are one-dimensional. Because the data points fall close to a curve y = x2, compared to the inde-
pendent case, a point (xi, yi) is not only closer to other points with similar x values, but also to
other points with x values close to-xi. Thus the average distance utilized by MeDiA is substan-
tially reduced. On the other hand, for dCov, two y values that are close may mean the corre-
sponding x values are either close or opposite. Thus dCov showed lower power than MeDiA.
Similar to the linear case, the reduction of a point’s distance to its nearest neighbor is not very
substantial compared to the independent case. Thus the power of MeDiANN and MI trailed
the other two methods.
In the variance association case, MeDiA again led the performance, followed by MeDiANN
and MI, while dCov trailed in the performance (Fig 2, upper-right panel). As illustrated by the
one-dimensional case, the data points tend to stay in a subspace, and the majority of the data
points are close to the center. Clearly the average pairwise distance tends to be much smaller
than the independent case, favoring MeDiA. At the same time, as the data points are crowded
near the origin, the distance of a data point to its nearest neighbor also tends to be small. Thus
MeDiANN and MI have reasonably good performance. On the other hand, data points with
similar y values may have x values that spread over a big range, causing difficulty for dCov.
In the sine function association case, dCov achieved higher statistical power than the other
three methods (Fig 2, lower-right panel). At the high noise level in our simulations, the bulk of
the data follows a relationship close to linear. Thus dCov showed the highest power as it is fa-
vored by linear relations. MiDiANN showed better power than MI at smaller sample size.
Overall, general dependency between groups of variables can take many forms. No method
is uniformly better than other methods. Each method is favored by certain types of associa-
tions, while having difficulty in other forms of associations. It appears that when the bulk of
the point cloud follows a relation that is close to linear, dCov has the highest statistical power.
When the underlying function is far from linear, MeDiA has the highest statistical power.
MeDiANN and MI appear to handle both cases reasonably well, but don’t excel in either. Be-
tween the two, MeDiANN has slightly better power than MI when the relation is close to linear,
while MI is better when the underlying function is curved.
Mean Distance Association and Nonlinear Gene Set Analysis
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Nonlinear gene set analysis using MeDiA
In this section we apply probabilistic association discovery on the analysis of gene sets. Unlike
traditional gene set analysis that seeks gene set-level differential expression [3–5], the class of
methods we discussed above seeks to find general dependencies between gene sets and the clin-
ical response variable(s). Using this type of methods allows multi-dimensional clinical
Fig 2. Comparison of statistical power under different scenarios.
doi:10.1371/journal.pone.0124620.g002
Mean Distance Association and Nonlinear Gene Set Analysis
PLOS ONE | DOI:10.1371/journal.pone.0124620 April 27, 2015 7 / 19
outcome, heterogeneity in the genes’ behavior within a gene set, as well as non-linear response
between genes and the clinical outcome variables. As MeDiA achieved very good overall statis-
tical power in our simulations, in this section, we use MeDiA for the data analysis.
We studied the dataset of gene expression in primary acute lymphoblastic leukemia (ALL)
associated with methotrexate (MTX) treatment [20]. The dataset is GSE10255 from the Gene
Expression Omnibus [21] (http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE10255).
The major clinical outcome is the change of circulating leukemia cells after initial MTX treat-
ment. We selected the probesets with known ENTREZ Gene IDs. When a gene was represented
by more than one probesets, we merged the corresponding probesets by taking the average ex-
pression values of the probesets. The data matrix contained 12704 genes and 161 samples.
We used a two-dimensional outcome—the day 0 white blood cell count, and the day 3 white
blood cell count, both on log scale. This type of multi-dimensional outcome is not accommo-
dated by traditional gene set analysis methods. For the gene sets, we used a previously described
procedure to reduce redundancy [9,22], and selected a group of Gene Ontology Biological Pro-
cess (BP) terms that are representative—577 biological process terms that contain a total of
10455 genes. We used MeDiA and its accompanying permutation test procedure to test for as-
sociation between each gene set and the clinical outcome vector. The p-values were adjusted to
False Discovery Rate using the Benjemini and Yekutieli procedure [23].
The top gene sets with FDR<0.01 are shown in Table 2. First we notice a number of im-
mune system GO terms in the table (label 1, Table 2). Besides being an anti-cancer agent, MTX
is also used to treat autoimmune diseases. It takes action by inhibiting enzymes in methyltrans-
ferase and purine metabolism, hence suppressing immune system function [24]. Because this
relation is obvious, we shall skip the discussion of details.
Another observation is that a number of signal transduction pathways are among the top
GO terms (label 2, Table 2). Some of the pathways were known to be regulated by MTX. The
NF-kappaB activation is suppressed by MTX through the inhibition of IkappaB alpha phos-
phorylation and degradation [25]. The relation between MTX or leukemia to other pathways
are not as clearly documented. But there has been some evidences. For example, PELO, which
is involved in both cell-matrix adhesion and integrin-mediated signaling pathway, was found
to be differentially expressed in AML [26]. It has been shown that MTX affects human bone
cell mechanotransduction by interfering with BMP4, which is involved in both integrin-medi-
ated signaling and regulation of protein kinase activity [27]. CAV1, a gene belonging to the cy-
tokine-mediated signaling pathway, was found to be one of the genes characterizing MTX non-
responders in patients with rheumatoid arthritis (RA) [28]. At the same time, CAV1 is consid-
ered a general tumor suppressor, the lack of expression of which was implicated in the patho-
genesis of many cancers, while the over expression of which has also been associated with
tumor progression and metastasis in prostate cancers [29]. With regard to the calcium-mediat-
ed signaling pathway, it has been shown that the interaction between CXCR4 and SDF-1 is a
key mediator of the resistence to chemotherapy in children with ALL [30]. In mouse experi-
ments, MTX treatment caused reduced CXCR4 and CXCL12 expression [31].
Four metabolism GO terms were among the list (label 3, Table 2), three of which were lipid
metabolism pathways. It has recently been shown that MTX potentiated glucose uptake and
lipid oxidation in skeletal muscle [32]. MTX was also found to improve lipid parameters and
fasting plasma glucose levels in a cross-sectional study of humans [33]. The specific pathways
detected by our method could indicate certain mechanistic links to explain the observations.
The GO term “stem cell maintenance” is the most significant in the list (label 4, Table 2).
Human hematopoietic stem cell maintenance mediated by the transcriptional coactivator
CITED2 contributes to leukemia maintenance [34]. In addition, in AML, the loss of Leo1 leads
to down-regulation of SOX2 and SOX4, potent oncogenes in myeloid transformation [35].
Mean Distance Association and Nonlinear Gene Set Analysis
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Two terms involved in cell adhesion were found in the list (label 5, Table 2). There have been
known links between leukemia or MTX to cell adhesion. A few genes in the collagen metabo-
lism pathway are altered with leukemia [36], and the overall expression level of collagen in-
creases with MTX treatment [37]. In addition, several cellular adhesion molecules are known
to be influenced by MTX [24]. A number of proteins in the membrane organization process
are influenced by leukemia (label 6, Table 2) [36,38]. Overall, almost all the GO biological pro-
cesses found by MeDiA make biological sense, indicating MeDiA is an effective method for
nonlinear gene set analysis.
Differential pathway interaction network discovery
The change of pathway interactions under different cell status is of crucial interest in biomedi-
cal study. For example, certain interactions between pathways may be amplified or suppressed
in disease state compared with healthy states. These changes in interaction may facilitate the
discovery of cell regulatory mechanism. We applied a network reverse engineering procedure
Table 2. Gene sets associated with the two-dimensional clinical outcome based on MeDiA.
GO term* FDR Name
4 GO:0019827 1.65E-06 stem cell maintenance
1 GO:0050852 1.47E-05 T cell receptor signaling pathway
3 GO:0006693 0.00042 prostaglandin metabolic process
5 GO:0033627 0.00047 cell adhesion mediated by integrin
1 GO:0030183 0.00051 B cell differentiation
1 GO:0045058 0.00072 T cell selection
3 GO:0009225 0.0027 nucleotide-sugar metabolic process
1 GO:0045730 0.0027 respiratory burst
GO:0000122 0.0031 negative regulation of transcription from RNA polymerase II promoter
2 GO:0007229 0.0031 integrin-mediated signaling pathway
6 GO:0051668 0.0031 localization within membrane
3 GO:0006633 0.0038 fatty acid biosynthetic process
6 GO:0008105 0.0038 asymmetric protein localization
1 GO:0019882 0.0038 antigen processing and presentation
2 GO:0043123 0.0038 positive regulation of I-kappaB kinase/NF-kappaB cascade
2 GO:0043627 0.0038 response to estrogen stimulus
GO:0001837 0.0047 epithelial to mesenchymal transition
1 GO:0006959 0.0047 humoral immune response
GO:0044419 0.0047 interspecies interaction between organisms
2 GO:0006469 0.0064 negative regulation of protein kinase activity
2 GO:0019221 0.0064 cytokine-mediated signaling pathway
2 GO:0019722 0.0064 calcium-mediated signaling
7 GO:0015012 0.0066 heparan sulfate proteoglycan biosynthetic process
3 GO:0042632 0.0079 cholesterol homeostasis
1 GO:0050869 0.0079 negative regulation of B cell activation
5 GO:0022407 0.0079 regulation of cell-cell adhesion
GO:0046677 0.0087 response to antibiotic
8 GO:0006919 0.0094 activation of caspase activity
GO:0006997 0.0099 nucleus organization
* Superscripts by the GO terms are for easy reference from the main text.
doi:10.1371/journal.pone.0124620.t002
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for pathway interaction to celiac disease data (NCBI data set GDS3646) and lung cancer data
(NCBI data set GDS2771), in which we were specifically interested in identifying pathway in-
teractions that are amplified or suppressed in the disease state.
The celiac disease data consists of gene expression levels of untouched primary leukocytes
from 132 unrelated celiac disease individuals and 22185 probesets [39]. Of the 132 individuals,
110 have sustained celiac disease, and 22 are healthy control individuals. Illumina
HumanWGv2 annotation data was used to group probe reads into 214 KEGG pathway groups,
covering 5201 genes of the data set. The lung cancer data consists of gene expression levels of
large airway epithelial cells from cigarette smokers without cancer, with cancer, and with sus-
pect lung cancer [40]. The probe reads were grouped into 214 KEGG pathways using Affyme-
trix Human Genome U133A database.
The amplified/suppressed pathway interactions were identified using the following
procedure:
1. For each pair of pathways i and j that don’t share any gene, a MeDiANN permutation test
of association was applied for the disease group and control group, respectively. Denote the
test p-value for disease group as pDij , and p
C
ij for control group.
2. Rank fpDij g and fpCij g from all i, j combinations in ascending order, and obtain the ranks
frDij g and frCij g. This is done for the two groups separately.
3. Calculate between state rank differences dij ¼ rDij  rCij .
4. Pathway pairs with rank change dij smaller than the 1% quantile in all {dij} are identified as
amplified in association at the disease state. Pairs with dij greater than 99% quantile are
identified as suppressed in association in disease state.
The identified pathways interactions are then checked for their biological meanings and
discussed below.
Celiac Disease Pathway Interaction. The newly developed method was used to analyze
the publically available Gene Expression Omnibus (GEO) data set GDS3646 (http://www.ncbi.
nlm.nih.gov/sites/GDSbrowser?acc=GDS3646). GDS3646 record is an expression analysis of
untouched primary leukocytes from unrelated celiac disease individuals [39]. In the study, the
gene expression in untouched primary leucocytes from individuals with celiac disease were
compared with an EBV-transformed HapMap B cell line data. Celiac disease, a multifactorial
disorder with complex genetics, is an enteropathy caused by autoimmune response against
wheat gluten, the protein component of the cereals wheat, rye and barley in genetically suscep-
tible individuals [41]. Patients with celiac disease have a wide spectrum of gastrointestinal and
extraintestinal manifestations, characterized by intestinal malabsorption and atrophy of intesti-
nal villi [42,43]. Celiac patients experience altered carbohydrate, lipid, peptide/protein, metab-
olism levels. Untreated celiac patients oxidize more carbohydrates as energy substrate
compared to treated subject [42].
The amplified pathway pairs are predominantly related to nutrition absorption and metabo-
lism, while a large proportion of the suppressed pathway pairs are between metabolism and sig-
nal transduction (Fig 3; S1 Table). Other pathways potentially linked with celiac disease were
also identified. For example, the 04062 chemokine signaling pathway has 6 connections. Che-
mokines are small peptides that provide directional cues for the cell trafficking and thus are
vital for protective inflammatory immune response that requires the recruitment of leukocytes
to the site of inflammation upon foreign insult. Celiac disease is known to be an inflammation
disease caused by dietary gluten. In genetically predisposed people, gliadin peptides (derivatives
of gluten) provokes immune response, which leads to the production of pro-inflammatory
Mean Distance Association and Nonlinear Gene Set Analysis
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cytokines and subsequent damage to, and increased permeability of the intestinal epithelium
[44–46].
Fig 3. Network interaction for celiac disease pathways.Red edge indicates that the interaction between connected pathways are amplified in disease
individuals. Blue edge indicates the interaction suppressed in disease individuals.
doi:10.1371/journal.pone.0124620.g003
Mean Distance Association and Nonlinear Gene Set Analysis
PLOS ONE | DOI:10.1371/journal.pone.0124620 April 27, 2015 11 / 19
Another example is the 02010 ABC transporters pathway. The results show that the interac-
tion between ABC transporter pathway and nitrogen metabolism pathway is suppressed in the
celiac disease patients. The ATP-binding cassette (ABC) transporters are protein families that
couple ATP hydrolysis to activate transport of a wide variety of substrates such as ions, sugars,
lipids, sterols, peptides, proteins, and drugs [47,48]. ABC transporters have been confirmed to
be related to celiac disease. It has been reported that a close association exists between poly-
morphism of TAP1 and TAP2 (ABC transporter gene) and disease susceptibility among south-
ern European populations [49]. The products of TAP1 and TAP2 are ABC transporters, which
are believed to transport antigenic peptides from the cytoplasm into the endoplasmic reticu-
lum. It was reported that nitrogen balance was modulated in celiac patients [50]. In addition,
both nitrate/nitrite are transported by ATP-binding cassette (ABC) transporters [51].
In addition, the relation between 04370 VEGF signaling pathway and several pathways is
found to be modulated in celiac patients, including 04340 hedgehog signaling, 510 N-Glycan
biosynthesis, 00860 porphyrin and chlorophyll metabolism, 00120 primary bile acid biosynthe-
sis. Vascular endothelial growth factor (VEGF) family and its receptor systems have been dem-
onstrated to be the fundamental regulator in the cell signaling of angiogenesis. Angiogenesis is
an essential biological process involved in the progression of a variety of major diseases such as
cancer, diabetes and inflammation [52]. It was reported that small-bowel mucosal vascular net-
work was altered in untreated coeliac disease. The study found that on a gluten-containing diet
the mucosal vasculature in the small intestine of untreated coeliac disease patients was altered
in overall organization as well as in the number and maturity of the vessels when compared to
healthy subjects. In patients on a gluten-free diet, the vasculature normalized parallel to muco-
sal recovery [53]. Angiogenesis is reported to be related to hedgehog signaling [54,55], bile acid
[56], glycan biosynthesis[57], porphyrin [58,59]. 04210 apoptosis pathway, the programmed
cell death, also shows a number of connections. Much evidence supported the increase of small
intestinal apoptosis in celiac disease [60]. Some other study demonstrated that enterocyte apo-
ptosis induced by activated intraepithelial lymphocytes is increased in celiac disease [61].
Lung Cancer Pathway Interaction. The newly developed method is also tested on
GDS2771 data set (http://www.ncbi.nlm.nih.gov/sites/GDSbrowser?acc=GDS2771), which is
the microarray data of large airway epithelial cells from cigarette smokers without cancer, with
cancer, and with suspect lung cancer. Many studies demonstrated the correlation of altered me-
tabolism with lung cancer, including basal metabolism [62–64], carbohydrate metabolism
[65,66], protein metabolism[66–68], lipid metabolism[69], and xenobiotic metabolism[70].
The result show that many relations between metabolism related pathways are regulated
(Fig 4; S2 Table). Take the TCA pathway as an example, the citrate cycle (TCA cycle, Krebs
cycle) is an important aerobic pathway for the final steps of the oxidation of carbohydrates and
fatty acids. Modulation of TCA cycle enzymes have been demonstrated in lung cancer. De-
creased activities of TCA cycle key enzymes were observed in lung cancer bearing animals [71].
Some specific pathways related to lung cancer are also caught on the list: It was shown that
the correlation between pathway 00072, the synthesis and degradation of ketone bodies path-
way and 04145, the phagosome pathway is amplified in lung cancer patients. Phagocytosis is
the cellular process of engulfing solid particles by the cell membrane to form an internal phago-
some, which is a central mechanism in both immune and apoptosis responses. There is a
broadly accepted view that bronchial neoplasms or its products suppress phagocytic functions
of alveolar macrophages [72]. The alveolar macrophage is believed to be of central importance
in the immune response against infection and tumor. It has been reported that there are type-
specific alterations in phagocytosis ability of alveolar macrophage in lung cancer patients,
which may result in an inability to stimulate anti-tumor immunity and subsequently cause ob-
served differences between lung cancer subgroups. Altered blood monocyte (BM) phagocytosis
Mean Distance Association and Nonlinear Gene Set Analysis
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ability was also observed in patients with lung cancer [73,74]. More importantly, some studies
proved that ketone bodies affect the phagocytic activity of macrophages and leukocytes [75].
Another interesting example is that the correlation between 00232, the pathway of caffeine
metabolism, and 00760, the nicotinate and nicotinamide metabolism, amplified in smokers
with lung cancer. First of all, both caffeine and nicotine metabolism are generally believed to re-
lated to the risk of lung cancer. Cigarette smoking is a clear risk factor for lung cancer. Even
though nicotine, one of the major ingredients and the causative agent for addiction of cigarette
smoking, is generally believed not a carcinogen by itself. However, several studies have shown
that nicotine can induce cell proliferation and angiogenesis [76]. Nicotine metabolism by cyto-
chrome P450 2A6 (CYP2A6) varies across ethnicity and race, which is indicated to be related
to smoking behavior and lung cancer risk [77,78]. The same as smoking, the consumption of
coffee is a very old and popular habit. Coffee contains catechins and flavonoids, which exhibit
anti-carcinogenic properties. Conversely, caffeine may elevate cancer risk through a variety of
Fig 4. Network interaction for lung cancer pathways.Red edge indicates that the interaction between connected pathways are amplified in disease
individuals. Blue edge indicates the interaction suppressed in disease individuals.
doi:10.1371/journal.pone.0124620.g004
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mechanisms [79,80]. Caffeine, an environmentally prominent phosphodiesterase, has been
proved to selectively stimulate the growth of pulmonary adenocarcinoma and small airway epi-
thelial cells [81]. Not only are both nicotine and caffeine related to lung cancer, but also many
evidences suggested that the metabolism of caffeine and nicotine are closely correlated. Caf-
feine is mainly metabolized by cytochrome P450 1A2 (CYP1A2). Actually caffeine metabolism
has been used as an in vivo marker of CYP1A2 activity, which has been clearly demonstrated
to be induced by cigarette smoking [82]. The difference of caffeine intake and plasma concen-
trations among smokers and nonsmokers was reported [83]. The results from 69 US samples
showed that smokers had significantly higher caffeine intake than nonsmokers and the ratio of
concentration/dose of caffeine was approximately four-fold higher in nonsmokers than in
smokers [83]. In animal studies, nicotine have been proved to induce the activity of several en-
zymes, including CYP1A2 [84]. It explains why nonsmokers have high plasma caffeine concen-
tration after intake of the same dose of caffeine compared to smokers. Some other research
articles reported that the combined NAT2/CYP1A2 status was related to lung adenocarcinoma
[78].
Discussion
In this paper we have discussed the general theory and applications of association discovery
using functions on the observation graph. Statistics of similar form to Eq 1 are capable of de-
tecting associations between continuous random vectors using permutation test of association
(Table 3). However, we would like to point out that Eq 1 is only one of the ways to test probabi-
listic association. For example, Brownian distance covariate (dCov) utilizes the covariates of be-
tween-observation distances calculated using either random vector. Its estimation is derived
from estimating the L2 distance between characteristics functions of joint distribution and
product of marginal distributions. It arrives at an observation distance product form. This is
different from Eq 1. We are confident that there are way more methods to test probabilistic as-
sociations to be discovered.
Mutual information estimation is derived from the estimation of joined entropy of variables
under consideration. There are two estimation methods generally used. (1) Reverse engineering
of joint density. This is the most popular method but is generally not applicable when the di-
mension under consideration goes too high. (2) Estimation of joint entropy using graph dis-
tance. This method as mentioned in the article can circumvent joint density estimation and is
more appropriate in high dimensional data analysis.
We have generalized the estimation of mean observation distance (MeDiA), mean nearest
neighbor observation distance (MeDiANN), and mutual information (MI) estimate into the
same framework of functions on the observation graph. Simulation study showed that the
three statistics have different performance in terms of statistical power under different scenari-
os. In hindsight, we realized that: testing of probabilistic association using observation distance
under the framework of Eq 1 actually rests on the testing of observation distance distributions.
More specifically, when random vectors X and Y under consideration are associated, their
Table 3. Summary of methods on Probabilistic association discovery discussed in this paper.
Name Statistic Inference
MeDiA Mean distance Permutation Test
MeDiANN Mean nearest neighbor distance Permutation Test
Mutual Information Mean log nearest neighbor distance Permutation Test
Brownian Cov Distance covariate Permutation Test
doi:10.1371/journal.pone.0124620.t003
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distribution of observation distance should be different from their independent counterpart ~X
and ~Y. In our upcoming work, we will explore an omnibus probabilistic association test based
on the observation distance distribution. We would expect this test to be more flexible com-
pared with the methods compared in this paper.
On the applications front, probabilistic dependency discovery methods such as MeDiA and
Brownian Covariate can be used to test the hypothesis that a gene set is associated with clinical
outcome variables. The association can involve multiple clinical variables, nonlinear interac-
tion, and be heterogeneous within the gene sets. We have also successfully applied the MeDiA
for the detection of differential interaction between gene sets under different treatment
conditions.
Conclusions
Overall, with the complexity of the biological system, and the documented presence of nonline-
ar and conditional dependencies, MeDiA and other probabilistic dependency discovery meth-
ods based on the observation graph are useful in unraveling high-throughput data to make
new biological discoveries.
Supporting Information
S1 File. Mathematical proof of Theorem 1.
(PDF)
S1 Table. Pathway pairs with amplified or suppressed relations in dataset GDS3646.
(XLSX)
S2 Table. Pathway pairs with amplified or suppressed relations in dataset GDS2771.
(XLSX)
Acknowledgments
The authors thank two anonymous reviewers whose comments helped significantly improve
the manuscript.
Author Contributions
Conceived and designed the experiments: HP TY. Performed the experiments: HP JM YB JL
TY. Analyzed the data: HP JM YB JL TY. Contributed reagents/materials/analysis tools: JL TY.
Wrote the paper: HP JM YB TY.
References
1. Ashburner M, Ball CA, Blake JA, Botstein D, Butler H, Cherry JM, et al. (2000) Gene ontology: tool for
the unification of biology. The Gene Ontology Consortium. Nat Genet 25: 25–29. PMID: 10802651
2. Kanehisa M, Goto S, Furumichi M, Tanabe M, Hirakawa M (2010) KEGG for representation and analy-
sis of molecular networks involving diseases and drugs. Nucleic Acids Res 38: D355–360. doi: 10.
1093/nar/gkp896 PMID: 19880382
3. Efron B, Tibshirani R (2007) On testing the significance of sets of genes. Ann Appl Stat 1: 107–129.
4. Goeman JJ, Buhlmann P (2007) Analyzing gene expression data in terms of gene sets: methodological
issues. Bioinformatics 23: 980–987. PMID: 17303618
5. Subramanian A, Tamayo P, Mootha VK, Mukherjee S, Ebert BL, Gillette MA, et al. (2005) Gene set en-
richment analysis: a knowledge-based approach for interpreting genome-wide expression profiles.
Proc Natl Acad Sci U S A 102: 15545–15550. PMID: 16199517
6. Yu T, SunW, Yuan S, Li KC (2005) Study of coordinative gene expression at the biological process
level. Bioinformatics 21: 3651–3657. PMID: 16076891
Mean Distance Association and Nonlinear Gene Set Analysis
PLOS ONE | DOI:10.1371/journal.pone.0124620 April 27, 2015 15 / 19
7. Choi Y, Kendziorski C (2009) Statistical methods for gene set co-expression analysis. Bioinformatics
25: 2780–2786. doi: 10.1093/bioinformatics/btp502 PMID: 19689953
8. Cho SB, Kim J, Kim JH (2009) Identifying set-wise differential co-expression in gene expression micro-
array data. BMC Bioinformatics 10: 109. doi: 10.1186/1471-2105-10-109 PMID: 19371436
9. Yu T, Bai Y (2011) Capturing changes in gene expression dynamics by gene set differential coordina-
tion analysis. Genomics 98: 469–477. doi: 10.1016/j.ygeno.2011.09.001 PMID: 21971296
10. Francesconi M, Lehner B (2014) The effects of genetic variation on gene expression dynamics during
development. Nature 505: 208–211. doi: 10.1038/nature12772 PMID: 24270809
11. Reshef DN, Reshef YA, Finucane HK, Grossman SR, McVean G, Turnbaugh PJ, et al. (2011) Detect-
ing novel associations in large data sets. Science 334: 1518–1524. doi: 10.1126/science.1205438
PMID: 22174245
12. Li KC (2002) Genome-wide coexpression dynamics: theory and application. Proc Natl Acad Sci U S A
99: 16875–16880. PMID: 12486219
13. Tostevin F, tenWolde PR (2009) Mutual Information between Input and Output Trajectories of Bio-
chemical Networks. Physical Review Letters 102.
14. Goria MN, Leonenko NN, Mergel VV, Inverardi PLN (2005) A new class of random vector entropy esti-
mators and its applications in testing statistical hypotheses. Journal of Nonparametric Statistics 17:
277–297.
15. Kraskov A, Stogbauer H, Grassberger P (2004) Estimating mutual information. Physical Review E 69.
16. Leonenko N, Pronzat L, Savani V (2008) A Class of Renyi Information Estimators for Multidimensional
Densities. Annals of Statistics 36: 2153–2182.
17. Szekely GJ, Rizzo ML (2009) Brownian Distance Covariance. Annals of Applied Statistics 3: 1236–
1265.
18. Szekely GJ, Rizzo ML, Bakirov NK (2007) Measuring and testing dependence by correlation of dis-
tances. Annals of Statistics 35: 2769–2794.
19. Bickel P, Breiman L (1983) Sums of functions of nearest neighbor distances, moment bounds, limit the-
orems and a goodness of fit test. Annals of Probability 11: 185–214.
20. Sorich MJ, Pottier N, Pei D, YangW, Kager L, Stocco G, et al. (2008) In vivo response to methotrexate
forecasts outcome of acute lymphoblastic leukemia and has a distinct gene expression profile. PLoS
Med 5: e83. doi: 10.1371/journal.pmed.0050083 PMID: 18416598
21. Barrett T, Edgar R (2006) Gene expression omnibus: microarray data storage, submission, retrieval,
and analysis. Methods Enzymol 411: 352–369. PMID: 16939800
22. Yu T, Bai Y (2011) Improving gene expression data interpretation by finding latent factors that co-regu-
late gene modules with clinical factors. BMCGenomics 12: 563. doi: 10.1186/1471-2164-12-563
PMID: 22087761
23. Benjamini Y, Yekutieli D (2001) The control of the false discovery rate in multiple testing under depen-
dency. Annals of Statistics 29: 1165–1188.
24. Wessels JA, Huizinga TW, Guchelaar HJ (2008) Recent insights in the pharmacological actions of
methotrexate in the treatment of rheumatoid arthritis. Rheumatology (Oxford) 47: 249–255. PMID:
18045808
25. Majumdar S, Aggarwal BB (2001) Methotrexate suppresses NF-kappaB activation through inhibition of
IkappaBalpha phosphorylation and degradation. J Immunol 167: 2911–2920. PMID: 11509639
26. Stirewalt DL, Meshinchi S, Kopecky KJ, FanW, Pogosova-Agadjanyan EL, Engel JH, et al. (2008)
Identification of genes with abnormal expression changes in acute myeloid leukemia. Genes Chromo-
somes Cancer 47: 8–20. PMID: 17910043
27. Elliot KJ, Millward-Sadler SJ, Wright MO, Robb JE, WallaceWH, Salter DM (2004) Effects of metho-
trexate on human bone cell responses to mechanical stimulation. Rheumatology (Oxford) 43: 1226–
1231. PMID: 15238642
28. Oliveira RD, Fontana V, Junta CM, Marques MM, Macedo C, Rassi DM, et al. (2012) Differential gene
expression profiles may differentiate responder and nonresponder patients with rheumatoid arthritis for
methotrexate (MTX) monotherapy and MTX plus tumor necrosis factor inhibitor combined therapy. J
Rheumatol 39: 1524–1532. doi: 10.3899/jrheum.120092 PMID: 22753658
29. Tsuji Y, Nakagawa T, Hatanaka M, Takeuchi T, Matsumoto E, Takenaka H, et al. (2006) Quantification
of caveolin isoforms using quantitative real-time RT-PCR, and analysis of promoter CpGmethylation of
caveolin-1alpha in human T cell leukemia cell lines. Int J Mol Med 18: 489–495. PMID: 16865235
30. Sison EA, Magoon D, Li L, Annesley CE, Rau RE, Small D, et al. (2014) Plerixafor as a chemosensitiz-
ing agent in pediatric acute lymphoblastic leukemia: efficacy and potential mechanisms of resistance to
CXCR4 inhibition. Oncotarget 5: 8947–8958. PMID: 25333254
Mean Distance Association and Nonlinear Gene Set Analysis
PLOS ONE | DOI:10.1371/journal.pone.0124620 April 27, 2015 16 / 19
31. Georgiou KR, Scherer MA, King TJ, Foster BK, Xian CJ (2012) Deregulation of the CXCL12/CXCR4
axis in methotrexate chemotherapy-induced damage and recovery of the bone marrow microenviron-
ment. Int J Exp Pathol 93: 104–114. doi: 10.1111/j.1365-2613.2011.00800.x PMID: 22220905
32. Pirkmajer S, Kulkarni SS, Tom RZ, Ross FA, Hawley SA, Hardie DG, et al. (2014) Methotrexate Pro-
motes Glucose Uptake and Lipid Oxidation in Skeletal Muscle via AMPK Activation. Diabetes.
33. Toms TE, Panoulas VF, John H, Douglas KM, Kitas GD (2009) Methotrexate therapy associates with
reduced prevalence of the metabolic syndrome in rheumatoid arthritis patients over the age of 60- more
than just an anti-inflammatory effect? A cross sectional study. Arthritis Res Ther 11: R110. doi: 10.
1186/ar2765 PMID: 19607680
34. Korthuis PM, Berger G, Bakker B, Rozenveld-Geugien M, Jaques J, de Haan G, et al. (2014) CITED2-
mediated human hematopoietic stem cell maintenance is critical for acute myeloid leukemia.
Leukemia.
35. Chong PS, Zhou J, Cheong LL, Liu SC, Qian J, Guo T, et al. (2014) LEO1 is regulated by PRL-3 and
mediates its oncogenic properties in acute myelogenous leukemia. Cancer Res 74: 3043–3053. doi:
10.1158/0008-5472.CAN-13-2321 PMID: 24686170
36. Shemon AN, Sluyter R, Wiley JS (2007) Rottlerin inhibits P2X(7) receptor-stimulated phospholipase D
activity in chronic lymphocytic leukaemia B-lymphocytes. Immunol Cell Biol 85: 68–72. PMID:
17130901
37. Jaskiewicz K, Voigt H, Blakolmer K (1996) Increased matrix proteins, collagen and transforming growth
factor are early markers of hepatotoxicity in patients on long-termmethotrexate therapy. J Toxicol Clin
Toxicol 34: 301–305. PMID: 8667468
38. Dubielecka PM, Jazwiec B, Potoczek S, Wrobel T, Miloszewska J, Haus O, et al. (2005) Changes in
spectrin organisation in leukaemic and lymphoid cells upon chemotherapy. Biochem Pharmacol 69:
73–85. PMID: 15588716
39. Heap GA, Trynka G, Jansen RC, Bruinenberg M, Swertz MA, Dinesen LC, et al. (2009) Complex nature
of SNP genotype effects on gene expression in primary human leucocytes. BMCMed Genomics 2: 1.
doi: 10.1186/1755-8794-2-1 PMID: 19128478
40. Spira A, Beane JE, Shah V, Steiling K, Liu G, Schembri F, et al. (2007) Airway epithelial gene expres-
sion in the diagnostic evaluation of smokers with suspect lung cancer. Nat Med 13: 361–366. PMID:
17334370
41. Alaedini A, Green PH (2005) Narrative review: celiac disease: understanding a complex autoimmune
disorder. Ann Intern Med 142: 289–298. PMID: 15710962
42. Malandrino N, Capristo E, Farnetti S, Leggio L, Abenavoli L, Addolorato G, et al. (2008) Metabolic and
nutritional features in adult celiac patients. Dig Dis 26: 128–133. doi: 10.1159/000116770 PMID:
18431062
43. Rubio-Tapia A, Murray JA (2010) Celiac disease. Curr Opin Gastroenterol 26: 116–122. doi: 10.1097/
MOG.0b013e3283365263 PMID: 20040864
44. Meresse B, Ripoche J, Heyman M, Cerf-Bensussan N (2009) Celiac disease: from oral tolerance to in-
testinal inflammation, autoimmunity and lymphomagenesis. Mucosal Immunol 2: 8–23. doi: 10.1038/
mi.2008.75 PMID: 19079330
45. Bianchi ML (2010) Inflammatory bowel diseases, celiac disease, and bone. Arch Biochem Biophys
503: 54–65. doi: 10.1016/j.abb.2010.06.026 PMID: 20599670
46. De Carolis S, Botta A, Fatigante G, Garofalo S, Ferrazzani S, Gasbarrini A, et al. (2004) Celiac disease
and inflammatory bowel disease in pregnancy. Lupus 13: 653–658. PMID: 15485096
47. Linton KJ (2007) Structure and function of ABC transporters. Physiology (Bethesda) 22: 122–130.
PMID: 17420303
48. Teodori E, Dei S, Martelli C, Scapecchi S, Gualtieri F (2006) The functions and structure of ABC trans-
porters: implications for the design of new inhibitors of Pgp and MRP1 to control multidrug resistance
(MDR). Curr Drug Targets 7: 893–909. PMID: 16842220
49. Tighe MR, Hall MA, Cardi E, Ashkenazi A, Lanchbury JS, Ciclitira PJ (1994) Associations between al-
leles of the major histocompatibility complex-encoded ABC transporter gene TAP2, HLA class II alleles,
and celiac disease susceptibility. Hum Immunol 39: 9–16. PMID: 8181966
50. Caughey RH, Mc CW, Kaye R (1955) Nitrogen balances in a patient with fibrocystic disease of the pan-
creas and a patient with the celiac syndrome and the effect of aureomycin. Pediatrics 16: 174–183.
PMID: 13245321
51. Maeda S, Omata T (2009) Nitrite transport activity of the ABC-type cyanate transporter of the cyano-
bacterium Synechococcus elongatus. J Bacteriol 191: 3265–3272. doi: 10.1128/JB.00013-09 PMID:
19286804
Mean Distance Association and Nonlinear Gene Set Analysis
PLOS ONE | DOI:10.1371/journal.pone.0124620 April 27, 2015 17 / 19
52. Shibuya M (2001) Structure and function of VEGF/VEGF-receptor system involved in angiogenesis.
Cell Struct Funct 26: 25–35. PMID: 11345501
53. Myrsky E, Syrjanen M, Korponay-Szabo IR, Maki M, Kaukinen K, Lindfors K (2009) Altered small-
bowel mucosal vascular network in untreated coeliac disease. Scand J Gastroenterol 44: 162–167.
doi: 10.1080/00365520802400875 PMID: 18985542
54. ChenW, Tang T, Eastham-Anderson J, Dunlap D, Alicke B, Nannini M, et al. (2011) Canonical hedge-
hog signaling augments tumor angiogenesis by induction of VEGF-A in stromal perivascular cells. Proc
Natl Acad Sci U S A 108: 9589–9594. doi: 10.1073/pnas.1017945108 PMID: 21597001
55. Koyama E, Young B, NagayamaM, Shibukawa Y, Enomoto-Iwamoto M, Iwamoto M, et al. (2007) Con-
ditional Kif3a ablation causes abnormal hedgehog signaling topography, growth plate dysfunction, and
excessive bone and cartilage formation during mouse skeletogenesis. Development 134: 2159–2169.
PMID: 17507416
56. Soma T, Kaganoi J, Kawabe A, Kondo K, Tsunoda S, Imamura M, et al. (2006) Chenodeoxycholic acid
stimulates the progression of human esophageal cancer cells: A possible mechanism of angiogenesis
in patients with esophageal cancer. Int J Cancer 119: 771–782. PMID: 16557574
57. Banerjee DK (2007) Requirement of protein kinase type I for cAMP-mediated up-regulation of lipid-
linked oligosaccharide for asparagine-linked protein glycosylation. Cell Mol Biol (Noisy-le-grand) 53:
55–63. PMID: 17531150
58. Lee JM, LeeWH, Kay HY, Kim ES, Moon A, Kim SG (2011) Hemin, an iron-binding porphyrin, inhibits
HIF-1alpha induction through its binding with heat shock protein 90. Int J Cancer.
59. Aviezer D, Cotton S, David M, Segev A, Khaselev N, Galili N, et al. (2000) Porphyrin analogues as
novel antagonists of fibroblast growth factor and vascular endothelial growth factor receptor binding
that inhibit endothelial cell proliferation, tumor progression, and metastasis. Cancer Res 60: 2973–
2980. PMID: 10850445
60. Moss SF, Attia L, Scholes JV, Walters JR, Holt PR (1996) Increased small intestinal apoptosis in coeli-
ac disease. Gut 39: 811–817. PMID: 9038662
61. Giovannini C, Sanchez M, Straface E, Scazzocchio B, Silano M, De Vincenzi M (2000) Induction of ap-
optosis in caco-2 cells by wheat gliadin peptides. Toxicology 145: 63–71. PMID: 10771132
62. Kurgan J (1969) [Basal metabolism in patients with lung cancer and the effect of corticosteroid therapy].
Gruzlica 37: 297–302. PMID: 5788092
63. Kurgan J (1970) [Basal metabolism in patients with lung cancer and its modification by corticotherapy].
Z Erkr Atmungsorgane Folia Bronchol 132: 181–186. PMID: 5203359
64. Tokovoi VA, Matytsin AN (1967) [Basal metabolism in patients with lung cancer]. Vopr Onkol 13: 74–
77. PMID: 5601552
65. Giovacchini G, Picchio M, Schipani S, Landoni C, Gianolli L, Bettinardi V, et al. (2009) Changes in glu-
cose metabolism during and after radiotherapy in non-small cell lung cancer. Tumori 95: 177–184.
PMID: 19579863
66. Heber D, Chlebowski RT, Ishibashi DE, Herrold JN, Block JB (1982) Abnormalities in glucose and pro-
tein metabolism in noncachectic lung cancer patients. Cancer Res 42: 4815–4819. PMID: 7127317
67. Koukourakis MI, Giatromanolaki A, Bougioukas G, Sivridis E (2007) Lung cancer: a comparative study
of metabolism related protein expression in cancer cells and tumor associated stroma. Cancer Biol
Ther 6: 1476–1479. PMID: 17881895
68. Gabazza EC, Taguchi O, Yoshida M, Yamakami T, Kobayashi H, Ibata H, et al. (1995) Neutrophil acti-
vation and collagen metabolism in lung cancer. Clin Chim Acta 236: 101–108. PMID: 7664461
69. Dessi S, Batetta B, Pulisci D, Spano O, Cherchi R, Lanfranco G, et al. (1992) Altered pattern of lipid me-
tabolism in patients with lung cancer. Oncology 49: 436–441. PMID: 1465281
70. Kiyohara C, Shirakawa T, Hopkin JM (2002) Genetic polymorphism of enzymes involved in xenobiotic
metabolism and the risk of lung cancer. Environ Health Prev Med 7: 47–59. doi: 10.1007/BF02897330
PMID: 21432264
71. Senthilnathan P, Padmavathi R, Magesh V, Sakthisekaran D (2006) Modulation of TCA cycle enzymes
and electron transport chain systems in experimental lung cancer. Life Sci 78: 1010–1014. PMID:
16143346
72. Sulowicz W (1983) Phagocytosis and peroxidase activity in neutrophils from peripheral blood of pa-
tients with malignant tumours of lung, stomach and large intestine. Folia Haematol Int Mag Klin Morphol
Blutforsch 110: 48–54. PMID: 6192054
73. Pouniotis DS, Plebanski M, Apostolopoulos V, McDonald CF (2006) Alveolar macrophage function is
altered in patients with lung cancer. Clin Exp Immunol 143: 363–372. PMID: 16412062
Mean Distance Association and Nonlinear Gene Set Analysis
PLOS ONE | DOI:10.1371/journal.pone.0124620 April 27, 2015 18 / 19
74. Hosker HS, Corris PA (1991) Alveolar macrophage and blood monocyte function in lung cancer. Can-
cer Detect Prev 15: 103–106. PMID: 2032250
75. Klucinski W, Degorski A, Miernik-Degorska E, Targowski S, Winnicka A (1988) Effect of ketone bodies
on the phagocytic activity of bovine milk macrophages and polymorphonuclear leukocytes. Zentralbl
Veterinarmed A 35: 632–639. PMID: 3142190
76. Puliyappadamba VT, Cheriyan VT, Thulasidasan AK, Bava SV, Vinod BS, Prabhu PR, et al. (2010) Nic-
otine-induced survival signaling in lung cancer cells is dependent on their p53 status while its down-reg-
ulation by curcumin is independent. Mol Cancer 9: 220. doi: 10.1186/1476-4598-9-220 PMID:
20727180
77. Derby KS, Cuthrell K, Caberto C, Carmella SG, Franke AA, Hecht SS, et al. (2008) Nicotine metabolism
in three ethnic/racial groups with different risks of lung cancer. Cancer Epidemiol Biomarkers Prev 17:
3526–3535. doi: 10.1158/1055-9965.EPI-08-0424 PMID: 19029401
78. Murray RP, Connett JE, Zapawa LM (2009) Does nicotine replacement therapy cause cancer? Evi-
dence from the Lung Health Study. Nicotine Tob Res 11: 1076–1082. doi: 10.1093/ntr/ntp104 PMID:
19571249
79. Martinet Y, Debry G (1992) [Effects of coffee on the respiratory system]. Rev Mal Respir 9: 587–592.
PMID: 1470751
80. Baker JA, McCann SE, Reid ME, Nowell S, Beehler GP, Moysich KB (2005) Associations between
black tea and coffee consumption and risk of lung cancer among current and former smokers. Nutr
Cancer 52: 15–21. PMID: 16090999
81. Al-Wadei HA, Takahashi T, Schuller HM (2006) Caffeine stimulates the proliferation of human lung ade-
nocarcinoma cells and small airway epithelial cells via activation of PKA, CREB and ERK1/2. Oncol
Rep 15: 431–435. PMID: 16391865
82. Zevin S, Benowitz NL (1999) Drug interactions with tobacco smoking. An update. Clin Pharmacokinet
36: 425–438. PMID: 10427467
83. de Leon J, Diaz FJ, Rogers T, Browne D, Dinsmore L, Ghosheh OH, et al. (2003) A pilot study of plas-
ma caffeine concentrations in a US sample of smoker and nonsmoker volunteers. Prog Neuropsycho-
pharmacol Biol Psychiatry 27: 165–171. PMID: 12551740
84. Carrillo JA, Benitez J (1996) CYP1A2 activity, gender and smoking, as variables influencing the toxicity
of caffeine. Br J Clin Pharmacol 41: 605–608. PMID: 8799528
Mean Distance Association and Nonlinear Gene Set Analysis
PLOS ONE | DOI:10.1371/journal.pone.0124620 April 27, 2015 19 / 19
